36544369|t|Citicoline: pharmacological and clinical review, 2022 update.
36544369|a|This review is based on the previous one published in 2016 (Secades JJ. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol 2016; 63 (Supl 3): S1-S73), incorporating 176 new references, having all the information available in the same document to facilitate the access to the information in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved the most important experimental and clinical data in both indications.
36544369	0	10	Citicoline	Chemical	MESH:D003566
36544369	134	144	Citicoline	Chemical	MESH:D003566
36544369	451	463	acute stroke	Disease	MESH:D020521
36544369	496	516	cognitive impairment	Disease	MESH:D003072
36544369	522	544	traumatic brain injury	Disease	MESH:D000070642
36544369	Association	MESH:D003566	MESH:D003072
36544369	Negative_Correlation	MESH:D003566	MESH:D000070642
36544369	Negative_Correlation	MESH:D003566	MESH:D020521

